Indication
Essential Fatty Acid Deficiency
2 clinical trials
3 products
Clinical trial
A Randomized, Double-Blind, Controlled, Clinical Trial to Evaluate the Risk of Developing Essential Fatty Acid Deficiency in Pediatric Patients, Including Neonates, Receiving Either Clinolipid (Lipid Injectable Emulsion, USP) 20% or Standard-of-Care Soybean Oil-Based Lipid Emulsion (Part A)Status: Completed, Estimated PCD: 2022-10-16
Product
ClinolipidProduct
IntralipidProduct
OmegavenClinical trial
Title: A Single-arm, Open-label, Prospective, Multicenter Safety Study to Evaluate the Occurrence of Essential Fatty Acid Deficiency (EFAD) in Pediatric Patients With Parenteral Nutrition-associated Cholestasis (PNAC) Who Require More Than Eight Weeks of Omegaven TreatmentStatus: Not yet recruiting, Estimated PCD: 2026-03-01